Biomed Realty Trust (BMR) Stock Price, News & Analysis

Company Overview

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Key Stats

• Today's Range: $3.77 to $4.20
• 50-Day Range: N/A
• 52-Week Range: $17.94 to $25.08
• Volume: 456,725 shs
• Average Volume: 3.29 million shs
• Market Capitalization: $51.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BMR Stock Analysis - Frequently Asked Questions

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) posted its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.04. The company's revenue for the quarter was up 5.4% compared to the same quarter last year.

When did Biomed Realty Trust IPO?

Biomed Realty Trust (BMR) raised $8 million in an initial public offering on Tuesday, February 28th 2023. The company issued 1,950,000 shares at a price of $4.00 per share.

Who are Biomed Realty Trust's major shareholders?

Top institutional investors of Biomed Realty Trust include International Assets Investment Management LLC (0.18%), Barclays PLC (0.16%), Barclays PLC (0.16%) and XTX Topco Ltd (0.09%).
View institutional ownership trends.

What other stocks do shareholders of Biomed Realty Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include NVIDIA (NVDA), Tesla (TSLA), Ford Motor (F), Meta Platforms (META), Broadcom (AVGO), Norwegian Cruise Line (NCLH) and NIO (NIO).

Company Calendar

• Last Earnings: 4/28/2015
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: Prepackaged software
• Sub-Industry: Office REITs
• Current Symbol: NYSE:BMR
• CUSIP: 09063H10
• CIK: 1289236
• Web: www.biomedrealty.com
• Phone: +1-858-4859840
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.02
• Current Ratio: 6.70
• Quick Ratio: 6.70

Sales & Book Value

• Annual Sales: $2.91 million
• Price / Sales: 17.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.80 per share
• Price / Book: 5.00

Miscellaneous

• Outstanding Shares: 12,880,000
• Free Float: N/A
• Market Cap: $51.52 million
• Optionable: Not Optionable
• Beta: 5.22